Dictionary

allow_url_fopen is ENABLED Dictionary Search

vasomotor

Synonyms

Adjective

1. constriction

2. dilation, dilatation

Usage
Nonhormonal Therapies for Vasomotor Symptoms of Menopause - Medscape Reference
Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation - Nature
FDA says "study may proceed" for Vistagen's refisolone nasal spray for vasomotor symptoms - Contemporary OB/GYN
Elinzanetant: Advancing Treatment for Vasomotor Symptoms - Pharmacy Times
Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care - Patient Care Online
Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms - News-Medical
Risk factors, management and consequences of severe menopausal vasomotor symptoms - Nature
Pathophysiology of Vasomotor Symptoms in Menopause - Contemporary OB/GYN
Elinzanetant Pooled Safety Analysis Supports FDA Approval Decision for Vasomotor Symptoms, With James A. Simon, MD - Patient Care Online
Estetrol Improves Vasomotor Symptoms With No BP Effects - Medscape
How African American Patients Are Affected By Vasomotor Symptoms - Contemporary OB/GYN
Key takeaways from real-world data of fezolinetant for vasomotor symptoms - Contemporary OB/GYN
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks - Patient Care Online
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep - Contemporary OB/GYN
Closing the Gap: Elinzanetant Demonstrates Efficacy for Vasomotor Symptoms in African American Women - Contemporary OB/GYN
A Case of a 54-Year-Old Woman with VMS and Cardiovascular Considerations - Contemporary OB/GYN
Midlife insulin levels influence timing and duration of menopausal vasomotor symptoms - News-Medical
Elinzanetant Reduces Postmenopausal Sleep Disturbances Independent of Improvements in Vasomotor Symptoms - Medscape
A New Era in Vasomotor Symptom Treatment - Patient Care Online
U.S. approval of a new hormone-free treatment option for moderate to severe vasomotor symptoms due to menopause - Bayer
Moderate to Severe Vasomotor Symptoms Suggest Perimenopause in Amenorrhea - Clinical Pain Advisor
Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause - Patient Care Online
Lynkuet® (elinzanetant) for the Treatment of Vasomotor Symptoms Due to Menopause - MPR - Medical Professionals Reference
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms - Pharmacy Times
EU approval for new hormone-free treatment option for vasomotor symptoms associated with menopause or caused by endocrine therapy for breast cancer - Bayer
Noema Pharma to Present Phase 2a Results for Cendifensine - GlobeNewswire
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials - Pharmacy Times
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD - The American Journal of Managed Care
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women - Wiley
Managing Vasomotor Symptoms With NK3 Receptor Antagonism - Patient Care Online
Dual NK3/NK1 Receptor Antagonism for Vasomotor Symptoms - Patient Care Online
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms - Contemporary OB/GYN
Vistagen Receives FDA "Study May Proceed" Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause - Yahoo Finance
Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape - Contemporary OB/GYN
New Research on Hormone-Free Hot Flash Treatments - Breast Cancer.org
Noema Pharma Announces Phase 2a Study Results with - GlobeNewswire
New nonhormonal therapies transform hot flash treatment in menopause - Contemporary OB/GYN
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause - The American Journal of Managed Care
Wearable device designed for perimenopause launches - Contemporary OB/GYN
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN
New menopause drug to target hot flashes without hormones gets FDA approval - ABC7 Chicago
Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape - Contemporary OB/GYN
Fezolinetant Can Reduce Menopause Symptoms in Women Who Cannot or Will Not Take Hormone Therapy - American Academy of Family Physicians | AAFP
Where Menopause Hits Hardest - HealthCentral
An update on the use of non-hormonal therapies for vasomotor symptoms of menopause - Royal Australian College of General Practitioners (RACGP)
Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms - Bayer
NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats - PharmaTimes
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies - The American Journal of Managed Care
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD - Contemporary OB/GYN
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause - Patient Care Online
Muna Al-Khaifi: Treating Vasomotor Symptoms in Breast Cancer is Not Just about Comfort - Oncodaily
Fezolinetant (Veozah) for the Treatment of Menopause Symptoms - American Academy of Family Physicians | AAFP
Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options - Contemporary OB/GYN
New Non-Hormonal Menopause Drug Backed by NICE - Medscape
Novel Nonhormonal Drug Approved for Menopause Hot Flashes - MedPage Today
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds - Medical Xpress
Plant-Based Estrogen Diminished Menopause Symptoms - MedPage Today
Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations - Pharmacy Times
Special Report: Identifying gaps in care - Contemporary OB/GYN
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - BioSpace
Bayer receives first approval worldwide for Lynkuet™ (elinzanetant) in the UK as treatment of moderate to severe vasomotor symptoms associated with menopause - Bayer
newsGP - Vasomotor symptoms key to perimenopause diagnosis - Royal Australian College of General Practitioners (RACGP)
How New Pathways Are Easing Vasomotor Symptoms in Breast Cancer Care - Contemporary OB/GYN
Hormone Therapy for Menopause: Timing, Safety, and Best Candidates - The American Journal of Managed Care
NICE recommends non-hormonal treatment for hot flushes - The Pharmaceutical Journal
Nonhormonal therapies transform menopause care in 2025 - Contemporary OB/GYN
Elinzanetant reduces vasomotor symptoms during breast cancer endocrine therapy - medwirenews.com
Dr Cardoso on the Effect of Elinzanetant on Vasomotor Symptoms in HR+ Breast Cancer - OncLive
Narcolepsy Patients Show Enhanced Brain Waste Clearance Through Compensatory Vasomotor Activity - Sleep Review
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Yahoo Finance
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - The New England Journal of Medicine
How a Mediterranean diet helps women manage menopausal symptoms - News-Medical
Elinzanetant for Vasomotor Symptoms From Endocrine Therapy for Breast Cancer - The ASCO Post
Heart Risks of Hormone Therapy for Hot Flashes Double Starting at This Age - MedPage Today
Fezolinetant shows real-world promise for menopause symptoms - PharmaTimes
You Don’t Have To Live With Hot Flashes And Night Sweats - Chatelaine
With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds - Fierce Pharma
Human NREM Sleep Promotes Brain-Wide Vasomotor and Respiratory Pulsations - Journal of Neuroscience
Phase III OASIS-4 Trial Shows Elinzanetant Significantly Reduces Endocrine Therapy–Related Vasomotor Symptoms in Patients with HR-Positive Breast Cancer - Applied Clinical Trials Online
New study may offer hope to women with hot flashes, night sweats - UVic News
Many physicians still consider VMS to be transient and inconsequential, but new research suggests otherwise—are you all caught up? - MDLinx
AbCellera begins Phase II ABCL635 trial for menopause-related VMS - Clinical Trials Arena
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library - Wiley
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause - GOV.UK
You know VMS is underdiagnosed. But are you part of the problem? - MDLinx
2023 Menopause Society Annual Meeting Highlights Vasomotor Symptoms Treatment - Endocrinology Advisor
Two types of vidian neurectomy show efficacy in treating allergic rhinitis and vasomotor rhinitis - Nature
VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer - 2 Minute Medicine
Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population‐Based Study - American Heart Association Journals
FDA accepts elinzanetant NDA for vasomotor symptoms in menopause - Contemporary OB/GYN
Bayer's challenger to Astellas hot flash drug wins first approval with UK OK - FirstWord Pharma
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women - 2 Minute Medicine
‘Ignoring hot flushes is wrong’: study challenges assumptions about perimenopause symptoms - The Guardian
Review: Nonhormone Therapies for Menopausal Hot Flashes - Cleveland Clinic
Nonhormonal Prescription Therapies for Moderate to Severe Menopause-Related Vasomotor Symptoms - Medical Professionals Reference
Elinzanetant Eases Vasomotor Symptoms in HR+ Breast Cancer - Docwire News
Vasomotor symptom frequency linked to diabetes risk - Contemporary OB/GYN
Vasomotor symptoms associated with diabetes risk - Contemporary OB/GYN
Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says - Patient Care Online
Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study - Bayer
Foreign Language Equivalents
Foreign Language Equivalents of 'vasomotor'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
vasomoter,   vasomptor,   vasomotir,   vasomootr,   vasomotot,   vaspmotor,   vasomootor,   vadomotor,   vasimotor,   vasoomotor,   vasomitor,   casomotor,   vsaomotor,   vaomotor,   vasomotro,   vasoomtor,   basomotor,   vasmootor,   vasomotpr,   vassomotor,   avsomotor,   vasomotoe,   vasomottor,   vasomotorr,   vasommotor,   vaso,otor,   vasomoto,   vasomoyor,   vasmotor,   vasomotr,   vaaomotor,   vsomotor,   vasomtor,   vasonotor,   vvasomotor,   vasomotoor,   vasootor,   asomotor,   vasomoror,   vasomtoor,   vaasomotor,   vaosmotor,   vssomotor,   vasomoor
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z